|
PGM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60059999998463E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55229999965201E-07 |
| Normal-vs-Stage2 |
2.606400E-02 |
| Normal-vs-Stage3 |
7.260000E-02 |
| Normal-vs-Stage4 |
1.404210E-02 |
| Stage1-vs-Stage2 |
4.903200E-01 |
| Stage1-vs-Stage3 |
2.341800E-02 |
| Stage1-vs-Stage4 |
3.373800E-01 |
| Stage2-vs-Stage3 |
3.816000E-01 |
| Stage2-vs-Stage4 |
9.125200E-01 |
| Stage3-vs-Stage4 |
3.950800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97410000002396E-06 |
| Normal-vs-AfricanAmerican |
5.400400E-02 |
| Normal-vs-Asian |
1.780970E-01 |
| Caucasian-vs-AfricanAmerican |
6.121800E-01 |
| Caucasian-vs-Asian |
4.500800E-01 |
| AfricanAmerican-vs-Asian |
3.803600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.583850E-04 |
| Normal-vs-Female |
1.75619999998045E-06 |
| Male-vs-Female |
1.827790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.158620E-01 |
| Normal-vs-Age(41-60Yrs) |
3.60230000000517E-05 |
| Normal-vs-Age(61-80Yrs) |
1.230090E-04 |
| Normal-vs-Age(81-100Yrs) |
1.114970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.407600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.352800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.524000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.429600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.682400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.763800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.075800E-02 |
| Normal-vs-Grade 2 |
2.79150000004336E-06 |
| Normal-vs-Grade 3 |
1.402170E-03 |
| Normal-vs-Grade 4 |
1.292490E-02 |
| Grade 1-vs-Grade 2 |
6.222800E-01 |
| Grade 1-vs-Grade 3 |
4.005600E-01 |
| Grade 1-vs-Grade 4 |
6.559600E-01 |
| Grade 2-vs-Grade 3 |
2.660800E-01 |
| Grade 2-vs-Grade 4 |
8.841400E-01 |
| Grade 3-vs-Grade 4 |
5.647600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.16050000004342E-06 |
| Normal-vs-ccB subtype |
8.599900E-04 |
| ccA subtype-vs-ccB subtype |
6.424400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.839700E-04 |
| Normal-vs-N1 |
8.164100E-02 |
| N0-vs-N1 |
3.184000E-01 |
|
|
